Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carcinoma that arises from the stomach and is characterized by the absence of microscopic features of glandular or squamous differentiation.
Biomarker and diagnostic research for undifferentiated carcinoma of stomach has been reported in the published literature.
1 clinical trial registered. Interventions under study include procedural interventions and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
201 publications have been identified in PubMed for undifferentiated carcinoma of stomach. Research spans Clinical Trial Publication (31%), Review / Meta-Analysis (25%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 62 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:39 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 49 | 25% |
Disease patterns and progression | 29 | 15% |
Laboratory research | 27 | 14% |
Testing and diagnosis research | 17 | 9% |
New treatment approaches | 6 | 3% |
Patient case studies | 5 | 3% |
Other research | 2 | 1% |
Lin Y (2026). [PMID: 41327861](https://pubmed.ncbi.nlm.nih.gov/41327861/). *Adv Sci (Weinh)*. [Clinical Trial Publication]
Wang Q (2026). [PMID: 41902313](https://pubmed.ncbi.nlm.nih.gov/41902313/). *Int J Cancer*. [Review / Meta-Analysis]
Souto M (2026). [PMID: 42214017](https://pubmed.ncbi.nlm.nih.gov/42214017/). *Eur J Gastroenterol Hepatol*. [Gene Therapy / Novel Therapeutics]
Kusano C (2026). [PMID: 41032470](https://pubmed.ncbi.nlm.nih.gov/41032470/). *Digestion*. [Review / Meta-Analysis]
Chen X (2026). [PMID: 41737224](https://pubmed.ncbi.nlm.nih.gov/41737224/). *Front Immunol*. [Basic Science / Preclinical]
Zhang R (2026). [PMID: 41330548](https://pubmed.ncbi.nlm.nih.gov/41330548/). *Endoscopy*. [Clinical Trial Publication]
Peng R (2026). [PMID: 41815546](https://pubmed.ncbi.nlm.nih.gov/41815546/). *Front Oncol*. [Case Report / Case Series]
Patel AK (2026). [PMID: 41499132](https://pubmed.ncbi.nlm.nih.gov/41499132/). *JAMA*. [Review / Meta-Analysis]
Shitara K (2026). [PMID: 42202319](https://pubmed.ncbi.nlm.nih.gov/42202319/). *N Engl J Med*. [Clinical Trial Publication]
Keam SJ (2026). [PMID: 41862758](https://pubmed.ncbi.nlm.nih.gov/41862758/). *Drugs*. [Review / Meta-Analysis]